HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leslie, R. D. G. Articles by Snieder, H. Search for Related Content PubMed PubMed Citation Articles by Leslie, R. D. G. Articles by Snieder, H. Social Bookmarking                What's this?

Level of an Advanced Glycated End Product Is Genetically Determined

A Study of Normal Twins

¹ Department of Diabetes and Metabolism, St. Bartholomew’s Hospital, London, U.K
² Division of Endocrinology and Diabetes, Department of Internal Medicine, University of Ulm, Ulm, Germany
³ Twin Research & Genetic Epidemiology Unit, St. Thomas’ Hospital, London, U.K
⁴ Georgia Prevention Institute, Department of Pediatrics, Medical College of Georgia, Augusta, Georgia

Reducing sugars react with amino groups in proteins, lipids, and nucleic acids to produce advanced glycation end products (AGEs), including N-carboxymethyl lysine (CML), which have been implicated in oxidative stress and vascular damage. The aim of this study was to determine whether genetic factors influence serum CML levels in normal subjects. We performed a classical twin study of CML in healthy nondiabetic female twins, 39 monozygotic and 45 dizygotic pairs, aged 21–74 years. Serum CML levels were estimated by enzyme-linked immunosorbent assay. Twin correlations (r) for serum CML levels were higher in monozygotic (r = 0.71) compared with dizygotic (r = 0.50) twin pairs, suggesting a substantial genetic effect and confirmed by quantitative genetic model fitting. Additive genetic effects (heritability) explained 74% (95% CI 58–84) of population variance in CML. Heritability (%) of fasting glucose (51%) and HbA_1c (62%) could not explain CML heritability, which was not associated with them. CML levels are, therefore, predominantly genetically determined and independent of genes influencing fasting glucose or HbA_1c. Thus familial, largely genetic factors influence AGE implicating these glycoxidation products in the genetic contribution to macro- and microvascular disease.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Bohlender, S. Franke, G. Stein, and G. Wolf Advanced glycation end products and the kidney Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659. [Abstract] [Full Text] [PDF]

				S. Katoh, M. Lehtovirta, J. Kaprio, V. Harjutsalo, M. Koskenvuo, J. Eriksson, N. Tajima, and J. Tuomilehto Genetic and Environmental Effects on Fasting and Postchallenge Plasma Glucose and Serum Insulin Values in Finnish Twins J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2642 - 2647. [Abstract] [Full Text] [PDF]